A new report by the Wall Street Journal (WSJ) reveals abuse of the 340B hospital markup program is getting worse as hospitals ...

The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief ...

The drug pricing program reveals systemic disparities in healthcare access and begins to address healthcare issues, ...

In just 10 years, annual 340B purchases grew more than 700%, from $7.5 billion in 2013 to $53.7 billion in 2022. Factors underlying this growth include. Exponential growth in participation by non ...

HB 2048 allows hospitals to receive massive discounts on prescription drugs without any requirement to pass along to patients ...

The government program, known as 340B, allows hospitals that care for many uninsured and low-income patients to purchase outpatient medicines at steep discounts. Hospitals can pocket the savings ...

A federal drug discount program called 340B, created in 1992, is the second largest drug program in the country. It was ...

The Department of Health and Human Services (HHS) has filed for summary judgment in its favor regarding lawsuits brought by ...

Companies such as Rescription, MakoRx and Liviniti sell benefit plans giving employers steep discounts for costly ...

$3M in Seed Funding and Proven Pilots Accelerate Path to Maximizing Essential Revenue for Healthcare Providers Serving Communities in Need Healthcare providers purchased a record $66 billion in ...

Fortunately, the 340B drug prescription program helps hospitals control costs and care for underserved communities by providing discounts on skyrocketing drug prices. Claims that the benefits of ...

The Trump administration is defending a Biden-era decision to reject drug manufacturer plans that would allow them to discount medicines through a rebate rather than up front under a federal drug ...